Intel chip cuts processing time

Article

Data intensive imaging scans, such as 4D CT brain perfusion studies, are processed 34% faster, when Vital Images’ Vitrea fX software runs on Intel’s new Xeon 5500 processor series.

Data intensive imaging scans, such as 4D CT brain perfusion studies, are processed 34% faster, when Vital Images’ Vitrea fX software runs on Intel’s new Xeon 5500 processor series.  The claim by Vital Images underscores the need for more efficient post processing of large datasets, such as those captured during cardiovascular and neurological scans. The company developed its volumetric compression software specifically to take advantage of Intel’s latest breed of microprocessor. Their combination substantially decreases the time needed to load clinical data sets, decreasing the time from scan to image, which enables physicians to treat critical care and other patients more efficiently and effectively, according to Vital Images.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.